Item 15. EXHIBITS, FINANCIAL STATEMENTS SCHEDULES
12K characters. Original on sec.gov ·
Item 15. EXHIBITS, FINANCIAL STATEMENTS SCHEDULES
- Financial Statements
The financial statements filed as part of this report are listed in the “Index to Financial Statements” under Part II, Item 8 of this report.
- Financial Statement Schedules
The following additional financial statement schedules should be considered in conjunction with our consolidated financial statements. All other financial statement schedules have been omitted because the required information is not present in amounts sufficient to require submission of the schedule, not applicable, or because the required information is included in the Consolidated Financial Statements or Notes thereto.
LUMENTUM HOLDINGS INC.
FINANCIAL STATEMENT SCHEDULES
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
| (in millions) | |||||||||||||||
| Balance at Beginning of Period | Increase (decrease) to Income Statement | Write Offs | Balance at End of Period | ||||||||||||
| Accounts receivable allowance: | |||||||||||||||
| Fiscal year ended June 30, 2018 | $ | 1.8 | $ | 0.9 | $ | (0.1 | ) | $ | 2.6 | ||||||
| Fiscal year ended July 1, 2017 | $ | 0.9 | $ | 1.0 | $ | (0.1 | ) | $ | 1.8 | ||||||
| Fiscal year ended July 2, 2016 | $ | 1.2 | $ | 0.6 | $ | (0.9 | ) | $ | 0.9 |
| (in millions) | ||||||||||||||||
| Description | Balance at Beginning of Period | Additions Charged to Expenses or Other Accounts* | Deductions Credited to Expenses or Other Accounts** | Balance at End of Period | ||||||||||||
| Deferred tax valuation allowance: | ||||||||||||||||
| Fiscal year ended June 30, 2018 | $ | 296.4 | $ | 234.1 | $ | (431.1 | ) | $ | 99.4 | |||||||
| Fiscal year ended July 1, 2017 | $ | 321.4 | $ | 16.7 | $ | (41.7 | ) | $ | 296.4 | |||||||
| Fiscal year ended July 2, 2016 | $ | 160.0 | $ | 214.3 | $ | (52.9 | ) | $ | 321.4 |
- Additions include current year additions charged to expenses and current year build due to increases in net deferred tax assets, return to provision true-ups, other adjustments to deferred taxes.
** Deductions include current year releases credited to expenses and current year reductions due to decreases in net deferred tax assets, return to provision true-ups, other adjustments to deferred taxes.
- Exhibits
The following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the Securities and Exchange Commission.
| Incorporated by Reference | Filed | |||||||||
| Exhibit No. | Exhibit Description | Form | Exhibit | Filing Date | Herewith | |||||
| 2.1 | Contribution Agreement | 8-K | 2.1 | 8/6/2015 | ||||||
| 2.1 | Agreement and Plan of Merger, dated as of March 11, 2018, by and among Lumentum Holdings Inc., Oclaro, Inc., Prota Merger Sub, Inc. and Prota Merger, LLC | 8-K | 2.1 | 3/12/2018 | ||||||
| 2.2 | Separation and Distribution Agreement | 8-K | 2.2 | 8/6/2015 | ||||||
| 3.1 | Amended and Restated Certificate of Incorporation | 8-K | 3.1 | 8/6/2015 | ||||||
| 3.2 | Amended and Restated Bylaws | 8-K | 3.2 | 8/6/2015 | ||||||
| 4.1 | Stockholder’s and Registration Rights Agreement | 8-K | 4.1 | 8/6/2015 | ||||||
| 4.2 | Indenture, dated March 8, 2017, between Lumentum Holdings Inc. and U.S. Bank National Association | 8-K | 4.1 | 3/9/2017 | ||||||
| 4.3 | Form of 0.250% Convertible Senior Notes due 2024 (included in Exhibit 4.2) | 8-K | 4.2 | 3/9/2017 | ||||||
| 10.1 | Tax Matters Agreement | 8-K | 10.1 | 8/6/2015 |
*Indicates management contract or compensatory plan or arrangement.
† The certifications furnished in Exhibits 32.1 and 32.2 that accompany this Amendment, are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Amendment, irrespective of any general incorporation language contained in such filing.
Previous: Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES · Next: Item 16. FORM 10-K SUMMARY.